AIHC Capital Management Ltd - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 5, 2026, for the 2025 Q4 period, AIHC Capital Management Ltd held in its portfolio 6 assets valued at $106,710,558 (i.e. $106.71M).

The most valuable assets in the portfolio included: REVOLUTION MEDICINES INC ($71.72M), PROTAGONIST THERAPEUTICS INC ($16.58M), and ARRIVENT BIOPHARMA INC ($12.97M).

The chart below shows the top 6 valuable assets, and the table below shows the top 6 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in AIHC Capital Management Ltd Portfolio

REVOLUTION MEDICINES INC

PROTAGONIST THERAPEUTICS INC

ARRIVENT BIOPHARMA INC

COGENT BIOSCIENCES INC

NOVABRIDGE BIOSCIENCES

KORRO BIO INC

AIHC Capital Management Ltd - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
REVOLUTION MEDICINES INC	900392	71716223	COM
PROTAGONIST THERAPEUTICS INC	189823	16579141	COM
ARRIVENT BIOPHARMA INC	644788	12973135	COM
COGENT BIOSCIENCES INC	100000	3552000	COM
NOVABRIDGE BIOSCIENCES	413979	1647636	SPONSORED ADS
KORRO BIO INC	30265	242423	COM